Technology Commercialization Office

Showing 13 result(s) for "Diagnostics"

A minimally invasive procedure to determine radiation toxicity in therapy patients or victims of nuclear accidents.

An enhanced nucleic acid amplification system that is more efficient and cost-effective than conventional polymerase chain reaction methods.

A novel microRNA expression pattern for the detection and treatment of pancreatic cancer.

Prognostic Indications of Canine Lymphoid Neoplasia using plasma DNA assays.

Realistic immunohistochemical stained tissue section databases for training, certification, and machine standards.

A non-invasive and automated tumor budding image analysis system for colorectal cancer. This program can detect tumor buds in traditional H&E stained sections without the need for manual assessment.

A diagnostic to provide more swift and reliant detection of Alzheimer's disease by monitoring the chemical modification of tau proteins in bodily fluids.

Polymethylmethacrylate (PMMA) is a useful material for development of assays, biochips, and other biological materials. However, PMMA makes for a difficult substrate because of complexities with respect to adhesion. This technology presents two new methods for enhanced protein binding onto PMMA.

A rapid diagnostic test for Thrombotic Thrombocytopenic Purpura.

A device for separating macromolecules in a solution of macromolecules having different molecular sizes